GMS-CAM: Regional Communicable Diseases Control

Details

Project 36672-012
Related Projects Search
Type Grant
Sector Health
Country Cambodia
Start 2005
End 2012
Status Closed
Last Edited 05 Jul 2021

Funding

US$('000) 11,170
Confinancing Source: World Health Organization

Project Description

The Greater Mekong Subregion (GMS) Regional Communicable Diseases Control Project was designed to develop the capacity to contain emerging diseases and reduce the burden of common neglected diseases in Cambodia, the Lao People-s Democratic Republic (Lao PDR), and Viet Nam (the CLV countries). The 4-year, $38.75 million project was supported by a $30 million grant from the Asian Development Bank (ADB), $0.9 million in cofinancing from the World Health Organization (WHO), $4.55 million from the Government of Viet Nam, $1.98 million from the Government of Cambodia, and $1.32 million from the Government of the Lao PDR. The expected project outcomes were (i) timely and adequate control of epidemics likely to have a major impact on public health and the economy in the region; (ii) improved coverage of prevention and care of communicable diseases in vulnerable populations; and (iii)improved know-how, policies, standards, and coordination among countries to improve communicable diseases control (CDC), including for HIV/AIDS, through regional cooperation. The project prioritized 26 provinces including 5 in Cambodia, 6 in the Lao PDR, and 15 in Viet Nam, but also supported disease outbreak control nationwide. The project aimed for a 15% reduction in communicable diseases in the targeted provinces and more for certain specific infections, thereby helping the CLV countries make progress toward the Millennium Development Goals (MDGs) of reducing the child mortality rate and containing HIV/AIDS and other infections. In each country, the Ministry of Health (MOH) was the executing agency. Implementation was undertaken by MOH departments, the 26 targeted provinces, and 9 national institutions. To facilitate the flow of funds for regional activities, $4.3 million, or 11% of the project funds, was administered by ADB as a regional pooled fund3 and managed by a regional coordination unit (RCU). ADB provided WHO with $1.6 million from the pooled fund, which, combined with $0.9 million of WHO, was used to engage international experts for the control of emerging diseases.




Progress (as of March 2021)

Project closed

Contacts

Contact 1
Contact Name de Wit, Vincent P.
Organization Asian Development Bank
Email
Contact 2
Contact Name -
Organization -
Email -

News and Multimedia


  • National infant mortality rate reduced from 66/1,000 to 45/1,000 by 2010. National under-five mortality rate reduced from 83/1,000 to 54/1,000 by 2010. HIV prevalence (15-49 years) reduced from 0.9% in 2006 to 0.7% in 2009.
  • In the 5 project provinces, the number of reported cases of acute watery diarrhea increased 3.37 times (cholera epidemic), bloody diarrhea increased 1.71 times, and ARI increased 2.18 times. National dengue incidence varied from 70.8/100,000 in 2005 to 83.4/100,000 in 2009, with an epidemic of 312.0/100,000 in 2007.
  • Prevalence of schistosomiasis in the 3 targeted provinces declined from a range of 6-15% in 2007 to 1-5% in 2009. Food-borne trematode infections declined from 10% in 2007 to 2% in 2009.
  • The proportion of responses to reported disease outbreaks, submission of zero reporting from health center increased from 85% in 2006 to 95% in 2009. 90% of disease outbreaks are reported within the first 24 hours compared to a target of 100%. 98% of disease outbreaks are investigated within 24 hours after reporting.
  • Dengue vector control in high risk locations was 93.2% in 2009. In 5 targeted provinces, 83% of pregnant women; 64% of pre-school children; and 53% of women with a child less than 2 years were treated for STH (2011 HH survey). Nationally, the number of patients receiving Highly Active Antiretroviral Therapy (HAART) increased from 12,355 in 2005 to 34,384 in 2009 (project procured medicine).